Cargando…

Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study

In clinically organ-confined prostate cancer patients, bloodstream tumour cell dissemination generally occurs, and may be enhanced by surgical prostate manipulation. To evaluate cancer-cell seeding impact upon patient recurrence-free survival, 155 patients were prospectively enrolled then followed....

Descripción completa

Detalles Bibliográficos
Autores principales: Eschwège, P, Moutereau, S, Droupy, S, Douard, R, Gala, J-L, Benoit, G, Conti, M, Manivet, P, Loric, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653745/
https://www.ncbi.nlm.nih.gov/pubmed/19223910
http://dx.doi.org/10.1038/sj.bjc.6604912
_version_ 1782165307002978304
author Eschwège, P
Moutereau, S
Droupy, S
Douard, R
Gala, J-L
Benoit, G
Conti, M
Manivet, P
Loric, S
author_facet Eschwège, P
Moutereau, S
Droupy, S
Douard, R
Gala, J-L
Benoit, G
Conti, M
Manivet, P
Loric, S
author_sort Eschwège, P
collection PubMed
description In clinically organ-confined prostate cancer patients, bloodstream tumour cell dissemination generally occurs, and may be enhanced by surgical prostate manipulation. To evaluate cancer-cell seeding impact upon patient recurrence-free survival, 155 patients were prospectively enrolled then followed. Here, 57 patients presented blood prostate cell shedding preoperatively and intraoperatively (group I). Of the 98 preoperatively negative patients, 53 (54%) remained negative (group II) and 45 (46%) became intraoperatively positive (group III). Median biological and clinical recurrence-free time was far shorter in group I (36.2 months, P<0.0001) than in group II (69.6 months) but did not significantly differ in group II and III (69.6 months vs 65.0). Such 5-year follow-up data show that preoperative circulating prostate cells are an independent prognosis factor of recurrence. Moreover, tumour handling induces cancer-cell seeding but surgical blood dissemination does not accelerate cancer evolution.
format Text
id pubmed-2653745
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-26537452010-02-24 Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study Eschwège, P Moutereau, S Droupy, S Douard, R Gala, J-L Benoit, G Conti, M Manivet, P Loric, S Br J Cancer Clinical Study In clinically organ-confined prostate cancer patients, bloodstream tumour cell dissemination generally occurs, and may be enhanced by surgical prostate manipulation. To evaluate cancer-cell seeding impact upon patient recurrence-free survival, 155 patients were prospectively enrolled then followed. Here, 57 patients presented blood prostate cell shedding preoperatively and intraoperatively (group I). Of the 98 preoperatively negative patients, 53 (54%) remained negative (group II) and 45 (46%) became intraoperatively positive (group III). Median biological and clinical recurrence-free time was far shorter in group I (36.2 months, P<0.0001) than in group II (69.6 months) but did not significantly differ in group II and III (69.6 months vs 65.0). Such 5-year follow-up data show that preoperative circulating prostate cells are an independent prognosis factor of recurrence. Moreover, tumour handling induces cancer-cell seeding but surgical blood dissemination does not accelerate cancer evolution. Nature Publishing Group 2009-02-24 2009-02-17 /pmc/articles/PMC2653745/ /pubmed/19223910 http://dx.doi.org/10.1038/sj.bjc.6604912 Text en Copyright © 2009 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Clinical Study
Eschwège, P
Moutereau, S
Droupy, S
Douard, R
Gala, J-L
Benoit, G
Conti, M
Manivet, P
Loric, S
Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study
title Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study
title_full Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study
title_fullStr Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study
title_full_unstemmed Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study
title_short Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study
title_sort prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653745/
https://www.ncbi.nlm.nih.gov/pubmed/19223910
http://dx.doi.org/10.1038/sj.bjc.6604912
work_keys_str_mv AT eschwegep prognosticvalueofprostatecirculatingcellsdetectioninprostatecancerpatientsaprospectivestudy
AT moutereaus prognosticvalueofprostatecirculatingcellsdetectioninprostatecancerpatientsaprospectivestudy
AT droupys prognosticvalueofprostatecirculatingcellsdetectioninprostatecancerpatientsaprospectivestudy
AT douardr prognosticvalueofprostatecirculatingcellsdetectioninprostatecancerpatientsaprospectivestudy
AT galajl prognosticvalueofprostatecirculatingcellsdetectioninprostatecancerpatientsaprospectivestudy
AT benoitg prognosticvalueofprostatecirculatingcellsdetectioninprostatecancerpatientsaprospectivestudy
AT contim prognosticvalueofprostatecirculatingcellsdetectioninprostatecancerpatientsaprospectivestudy
AT manivetp prognosticvalueofprostatecirculatingcellsdetectioninprostatecancerpatientsaprospectivestudy
AT lorics prognosticvalueofprostatecirculatingcellsdetectioninprostatecancerpatientsaprospectivestudy